Related Experiment Video
Updated: Mar 31, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-29 Induces K562 Cell Apoptosis by Down-Regulating FoxM1
Xiaofang Wang1, Hua Zhong1, Lei Wang1
1Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China (mainland).
Background:
Leukemia seriously threatens human life and health. MicroRNAs can regulate cell growth, proliferation, and death. This article investigated the role of miR-29 on regulating leukemia cell growth, proliferation, and apoptosis.
Material And Methods:
miR-29 and scramble miRNA were transfected to K562 cells. MTT assay, colony formation assay, caspase-3 activity detection, and flow cytometry were applied to test miR-29 effect on cell growth, proliferation, and apoptosis. Western blot was used to detect Forkhead box protein M1 (FoxM1) protein expression. After we transfected miR-29, K562 cells were transfected with FoxM1 siRNA to test cell apoptosis.
Results:
K562 cell growth and proliferation were inhibited after transfection with miR-29. Apoptosis phenome and caspase-3 activation were observed. FoxM1 level decreased. SiRNA FoxM1 enhanced miR-29-induced K562 cell apoptosis. FoxM1 overexpression suppressed miR-26-induced K562 cell apoptosis.
Conclusions:
MiR-29 restrained K562 cell growth and proliferation. MiR-29 induced K562 cell apoptosis through down-regulating FoxM1.
Insights
MicroRNA-29 (miR-29) inhibits leukemia cell growth and proliferation. It induces apoptosis by down-regulating Forkhead box protein M1 (FoxM1) in K562 cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Leukemia poses a significant threat to human health.
- MicroRNAs play crucial roles in regulating cell growth, proliferation, and apoptosis.
- Understanding specific microRNA functions is vital for leukemia research.
Purpose of the Study:
- To investigate the role of miR-29 in regulating leukemia cell growth, proliferation, and apoptosis.
- To elucidate the molecular mechanism underlying miR-29's effects on leukemia cells.
- To assess the potential of miR-29 as a therapeutic target in leukemia.
Main Methods:
- Transfection of K562 cells with miR-29 and scramble miRNA.
- Assessment of cell growth and proliferation using MTT and colony formation assays.
- Detection of apoptosis via caspase-3 activity and flow cytometry.
- Western blot analysis to determine Forkhead box protein M1 (FoxM1) expression levels.
- Validation of miR-29's mechanism using siRNA targeting FoxM1 and FoxM1 overexpression.
Main Results:
- miR-29 transfection significantly inhibited K562 cell growth and proliferation.
- Increased apoptosis and caspase-3 activation were observed in miR-29 transfected cells.
- Down-regulation of FoxM1 protein expression was detected following miR-29 transfection.
- siRNA-mediated knockdown of FoxM1 enhanced miR-29-induced apoptosis.
- Overexpression of FoxM1 suppressed miR-29-induced apoptosis.
Conclusions:
- miR-29 effectively restrains K562 leukemia cell growth and proliferation.
- miR-29 induces apoptosis in K562 cells primarily through the down-regulation of FoxM1.
- These findings highlight miR-29 as a potential therapeutic agent targeting FoxM1 in leukemia treatment.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Extrinsic Apoptotic Pathway
Abnormal Proliferation

